{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:26:32Z","timestamp":1793665592755,"version":"4.5.1"},"reference-count":100,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T00:00:00Z","timestamp":1665014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Inflammation is a response of the body to external stimuli (eg. chemical irritants, bacteria, viruses, etc.), and when the stimuli are persistent, they tend to trigger chronic inflammation. The presence of chronic inflammation is an important component of the tumor microenvironment produced by a variety of inflammatory cells (eg. macrophages, neutrophils, leukocytes, etc.). The relationship between chronic inflammation and cancer development has been widely accepted, and chronic inflammation has been associated with the development of many cancers, including chronic bronchitis and lung cancer, cystitis inducing bladder cancer. Moreover, chronic colorectitis is more likely to develop into colorectal cancer. Therefore, the specific relationship and cellular mechanisms between inflammation and cancer are a hot topic of research. Recent studies have identified phosphodiesterase 4B (PDE4B), a member of the phosphodiesterase (PDEs) protein family, as a major cyclic AMP (cAMP) metabolizing enzyme in inflammatory cells, and the therapeutic role of PDE4B as chronic inflammation, cancer. In this review, we will present the tumors associated with chronic inflammation, and PDE4B potential clinical application.<\/jats:p>","DOI":"10.3389\/fphar.2022.982130","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T04:55:30Z","timestamp":1665032130000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":57,"title":["The regulatory role of PDE4B in the progression of inflammatory function study"],"prefix":"10.3389","volume":"13","author":[{"given":"Yue","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxiang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuixia","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.bcp.2004.09.012","article-title":"Dexamethasone down-regulates cAMP-phosphodiesterase in human osteosarcoma cells","volume":"69","author":"Ahlstr\u00f6m","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1111\/odi.12275","article-title":"Cyclic nucleotide phosphodiesterases: Important signaling modulators and therapeutic targets","volume":"21","author":"Ahmad","year":"2015","journal-title":"Oral Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1039\/d0md00423e","article-title":"Pyridazinone derivatives as potential anti-inflammatory agents: Synthesis and biological evaluation as PDE4 inhibitors","volume":"12","author":"Allart-Simon","year":"2021","journal-title":"RSC Med. Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1080\/10428194.2019.1633628","article-title":"The neutrophil\/lymphocyte ratio \u22653.5 is a prognostic marker in diffuse large B-cell lymphoma: A retrospective analysis from the database of the Italian regional network 'rete ematologica del lazio per i linfomi' (RELLI)","volume":"60","author":"Annibali","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"B5","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.1002\/cncr.30857","article-title":"Young adult survivors of childhood acute lymphoblastic leukemia show evidence of chronic inflammation and cellular aging","volume":"123","author":"Ariffin","year":"2017","journal-title":"Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3797\/scipharm.1404-08","article-title":"Selective phosphodiesterase 4B inhibitors: A review","volume":"82","author":"Azam","year":"2014","journal-title":"Sci. Pharm."},{"key":"B7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1210\/er.2013-1053","article-title":"Clinical and molecular genetics of the phosphodiesterases (PDEs)","volume":"35","author":"Azevedo","year":"2014","journal-title":"Endocr. Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1124\/pr.58.3.5","article-title":"Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use","volume":"58","author":"Bender","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: A review","volume":"325","author":"Biller","year":"2021","journal-title":"Jama"},{"key":"B10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.theriogenology.2019.03.011","article-title":"Expression, localization, and concentration of A-kinase anchor protein 4 (AKAP4) and its precursor (proAKAP4) in equine semen: Promising marker correlated to the total and progressive motility in thawed spermatozoa","volume":"131","author":"Blommaert","year":"2019","journal-title":"Theriogenology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/978-3-319-58811-7_4","article-title":"The PDE4 cAMP-specific phosphodiesterases: Targets for drugs with antidepressant and memory-enhancing action","volume":"17","author":"Bolger","year":"2017","journal-title":"Adv. Neurobiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1109\/TMI.2020.3022034","article-title":"Lesion-Harvester: Iteratively mining unlabeled lesions and hard-negative examples at scale","volume":"40","author":"Cai","year":"2021","journal-title":"IEEE Trans. Med. Imaging"},{"key":"B13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12868-017-0396-6","article-title":"Altered phosphorylation, electrophysiology, and behavior on attenuation of PDE4B action in hippocampus","volume":"18","author":"Campbell","year":"2017","journal-title":"BMC Neurosci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3760\/cma.j.cn112152-20191204-00784","article-title":"Mechanism of TRIM27 promoting inflammatory response in lung cancer cells","volume":"43","author":"Chen","year":"2021","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1002\/cam4.2934","article-title":"Integrated bioinformatics analysis of the crucial candidate genes and pathways associated with glucocorticoid resistance in acute lymphoblastic leukemia","volume":"9","author":"Chen","year":"2020","journal-title":"Cancer Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/bfgp\/elaa001","article-title":"CRISPR\/Cas9 for cancer treatment: Technology, clinical applications and challenges","volume":"19","author":"Cheng","year":"2020","journal-title":"Brief. Funct. Genomics"},{"key":"B17","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0140-6736(19)32007-0","article-title":"Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): A prospective cohort study","volume":"395","author":"Dagenais","year":"2020","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nrc2090","article-title":"Inflammation in prostate carcinogenesis","volume":"7","author":"De Marzo","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","article-title":"Cancer-related inflammation and treatment effectiveness","volume":"15","author":"Diakos","year":"2014","journal-title":"Lancet. Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e1003065","DOI":"10.1371\/journal.pgen.1003065","article-title":"Recurrent targeted genes of Hepatitis B virus in the liver cancer genomes identified by a next-generation sequencing-based approach","volume":"8","author":"Ding","year":"2012","journal-title":"PLoS Genet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s43046-021-00088-y","article-title":"Reviewing cancer's biology: An eclectic approach","volume":"33","author":"Diori Karidio","year":"2021","journal-title":"J. Egypt. Natl. Canc. Inst."},{"key":"B23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1465-9921-10-39","article-title":"A multi-target antisense approach against PDE4 and PDE7 reduces smoke-induced lung inflammation in mice","volume":"10","author":"Fortin","year":"2009","journal-title":"Respir. Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nri3041","article-title":"The anti-inflammatory effects of exercise: Mechanisms and implications for the prevention and treatment of disease","volume":"11","author":"Gleeson","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: Triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"B26","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.virol.2012.09.013","article-title":"Experimental infection of United States swine with a Chinese highly pathogenic strain of porcine reproductive and respiratory syndrome virus","volume":"435","author":"Guo","year":"2013","journal-title":"Virology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1158\/1055-9965.EPI-13-1126","article-title":"Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial","volume":"23","author":"Gurel","year":"2014","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1158\/1535-7163.MCT-14-0297","article-title":"Integrated analysis of transcriptomes of cancer cell lines and patient samples reveals STK11\/LKB1-driven regulation of cAMP phosphodiesterase-4D","volume":"13","author":"He","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1038\/bjc.2014.22","article-title":"The cAMP phosphodiesterase-4D7 (PDE4D7) is downregulated in androgen-independent prostate cancer cells and mediates proliferation by compartmentalising cAMP at the plasma membrane of VCaP prostate cancer cells","volume":"110","author":"Henderson","year":"2014","journal-title":"Br. J. Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ceca.2009.08.007","article-title":"L-type channel inhibition by CB1 cannabinoid receptors is mediated by PTX-sensitive G proteins and cAMP\/PKA in GT1-7 hypothalamic neurons","volume":"46","author":"Hoddah","year":"2009","journal-title":"Cell Calcium"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1038\/s41388-020-1258-8","article-title":"PDE4 subtypes in cancer","volume":"39","author":"Hsien Lai","year":"2020","journal-title":"Oncogene"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1158\/0008-5472.CAN-19-4044","article-title":"FTO-dependent N (6)-methyladenosine modifications inhibit ovarian cancer stem cell self-renewal by blocking cAMP signaling","volume":"80","author":"Huang","year":"2020","journal-title":"Cancer Res."},{"key":"B33","first-page":"163","article-title":"Type 4 phosphodiesterase-dependent pathways: Role in inflammatory processes","volume":"57","author":"Jacob","year":"2002","journal-title":"Therapie"},{"key":"B34","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1053\/j.sult.2018.11.011","article-title":"Immune-mediated lung diseases","volume":"40","author":"Jacobs","year":"2019","journal-title":"Semin. Ultrasound CT MR"},{"key":"B35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/BF02737809","article-title":"Expression and regulation of mRNA for distinct isoforms of cAMP-specific PDE-4 in mitogen-stimulated and leukemic human lymphocytes","volume":"28","author":"Jiang","year":"1998","journal-title":"Cell biochem. Biophys."},{"key":"B36","doi-asserted-by":"publisher","first-page":"7628","DOI":"10.1073\/pnas.122041599","article-title":"Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses","volume":"99","author":"Jin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.4049\/jimmunol.175.3.1523","article-title":"Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages","volume":"175","author":"Jin","year":"2005","journal-title":"J. Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41467-019-13855-2","article-title":"Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility","volume":"11","author":"Kachuri","year":"2020","journal-title":"Nat. Commun."},{"key":"B39","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/pros.21478","article-title":"Downregulation of phosphodiesterase 4B (PDE4B) activates protein kinase A and contributes to the progression of prostate cancer","volume":"72","author":"Kashiwagi","year":"2012","journal-title":"Prostate"},{"key":"B40","doi-asserted-by":"publisher","first-page":"102673","DOI":"10.1016\/j.dnarep.2019.102673","article-title":"Inflammation-induced DNA damage, mutations and cancer","volume":"83","author":"Kay","year":"2019","journal-title":"DNA Repair (Amst)"},{"key":"B41","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.bbrc.2018.12.004","article-title":"Phosphodiesterase 4B is an effective therapeutic target in colorectal cancer","volume":"508","author":"Kim","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B42","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.gene.2015.01.001","article-title":"MicroRNA-124 regulates glucocorticoid sensitivity by targeting phosphodiesterase 4B in diffuse large B cell lymphoma","volume":"558","author":"Kim","year":"2015","journal-title":"Gene"},{"key":"B43","doi-asserted-by":"publisher","first-page":"6153","DOI":"10.1182\/blood-2009-02-206128","article-title":"Rational combined targeting of phosphodiesterase 4B and SYK in DLBCL","volume":"113","author":"Kim","year":"2009","journal-title":"Blood"},{"key":"B44","doi-asserted-by":"publisher","first-page":"4751","DOI":"10.1091\/mbc.e09-01-0019","article-title":"Expression and activity of phosphodiesterase isoforms during epithelial mesenchymal transition: The role of phosphodiesterase 4","volume":"20","author":"Kolosionek","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1038\/ncomms2674","article-title":"Inhibition of PDE4B suppresses inflammation by increasing expression of the deubiquitinase CYLD","volume":"4","author":"Komatsu","year":"2013","journal-title":"Nat. Commun."},{"key":"B46","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11845-016-1464-0","article-title":"From inflammation to cancer","volume":"186","author":"Korniluk","year":"2017","journal-title":"Ir. J. Med. Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.trsl.2018.05.011","article-title":"Epigenetic regulators of programmed death-ligand 1 expression in human cancers","volume":"202","author":"Kumar","year":"2018","journal-title":"Transl. Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1002\/hep.32232","article-title":"IL-6-induced cGGNBP2 encodes a protein to promote cell growth and metastasis in intrahepatic cholangiocarcinoma","volume":"75","author":"Li","year":"2022","journal-title":"Hepatology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1533033819849068","DOI":"10.1177\/1533033819849068","article-title":"Colon cancer cell secretes EGF to promote M2 polarization of TAM through EGFR\/PI3K\/AKT\/mTOR pathway","volume":"18","author":"Lian","year":"2019","journal-title":"Technol. Cancer Res. Treat."},{"key":"B50","doi-asserted-by":"publisher","first-page":"118249","DOI":"10.1016\/j.envpol.2021.118249","article-title":"A review on methodology in O(3)-NOx-VOC sensitivity study","volume":"291","author":"Liu","year":"2021","journal-title":"Environ. Pollut."},{"key":"B51","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41523-021-00278-w","article-title":"Whole-exome sequencing identifies somatic mutations and intratumor heterogeneity in inflammatory breast cancer","volume":"7","author":"Luo","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/j.bbrc.2014.07.024","article-title":"Blockade of PDE4B limits lung vascular permeability and lung inflammation in LPS-induced acute lung injury","volume":"450","author":"Ma","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B53","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1186\/s12885-016-2980-z","article-title":"Phosphodiesterases in non-neoplastic appearing colonic mucosa from patients with colorectal neoplasia","volume":"16","author":"Mahmood","year":"2016","journal-title":"BMC cancer"},{"key":"B54","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.cell.2017.08.012","article-title":"Cancer evolution constrained by the immune microenvironment","volume":"170","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"B55","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1024\/0040-5930\/a001127","article-title":"Acute lymphoblastic leukemia - diagnosis and therapy","volume":"76","author":"Medinger","year":"2019","journal-title":"Ther. Umsch."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1172\/JCI35073","article-title":"DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice","volume":"118","author":"Meira","year":"2008","journal-title":"J. Clin. Invest."},{"key":"B57","first-page":"589","article-title":"Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia","volume":"8","author":"Moon","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1111\/cts.13266","article-title":"Population genetics of PDE4B (phosphodiesterase-4B) in neglected Native Americans: Implications for cancer pharmacogenetics","volume":"15","author":"Moreira","year":"2022","journal-title":"Clin. Transl. Sci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e57326","DOI":"10.1371\/journal.pone.0057326","article-title":"Genome wide mapping reveals PDE4B as an IL-2 induced STAT5 target gene in activated human PBMCs and lymphoid cancer cells","volume":"8","author":"Nagy","year":"2013","journal-title":"PLoS One"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1038\/s41375-019-0492-y","article-title":"Disruption of the Myc-PDE4B regulatory circuitry impairs B-cell lymphoma survival","volume":"33","author":"Nam","year":"2019","journal-title":"Leukemia"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.2174\/1389450120666190618123846","article-title":"PI3K\/akt\/mTOR pathway as a therapeutic target for colorectal cancer: A review of preclinical and clinical evidence","volume":"20","author":"Narayanankutty","year":"2019","journal-title":"Curr. Drug Targets"},{"key":"B62","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.21873\/anticanres.11762","article-title":"Apremilast induces apoptosis of human colorectal cancer cells with mutant KRAS","volume":"37","author":"Nishi","year":"2017","journal-title":"Anticancer Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1248\/bpb.b15-00652","article-title":"Pharmacological profile of GPD-1116, an inhibitor of phosphodiesterase 4","volume":"39","author":"Nose","year":"2016","journal-title":"Biol. Pharm. Bull."},{"key":"B64","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12943-017-0707-7","article-title":"Neutrophils in cancer: Prognostic role and therapeutic strategies","volume":"16","author":"Ocana","year":"2017","journal-title":"Mol. Cancer"},{"key":"B65","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.4049\/jimmunol.178.8.4820","article-title":"Differential expression and function of phosphodiesterase 4 (PDE4) subtypes in human primary CD4+ T cells: Predominant role of PDE4D","volume":"178","author":"Peter","year":"2007","journal-title":"J. Immunol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"e1007611","DOI":"10.1371\/journal.pgen.1007611","article-title":"The conserved protective cyclic AMP-phosphodiesterase function PDE4B is expressed in the adenoma and adjacent normal colonic epithelium of mammals and silenced in colorectal cancer","volume":"14","author":"Pleiman","year":"2018","journal-title":"PLoS Genet."},{"key":"B67","first-page":"17","volume-title":"Nursing standard","year":"2016"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/onc.2012.136","article-title":"Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF","volume":"32","author":"Pullamsetti","year":"2013","journal-title":"Oncogene"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"37922","DOI":"10.1038\/srep37922","article-title":"A-Kinase Anchoring Protein 4 (AKAP4) is an ERK1\/2 substrate and a switch molecule between cAMP\/PKA and PKC\/ERK1\/2 in human spermatozoa","volume":"6","author":"Rahamim Ben-Navi","year":"2016","journal-title":"Sci. Rep."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/ajh.23566","article-title":"The lymphocyte to monocyte ratio improves the IPI-risk definition of diffuse large B-cell lymphoma when rituximab is added to chemotherapy","volume":"88","author":"Rambaldi","year":"2013","journal-title":"Am. J. Hematol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1182\/blood-2009-11-252668","article-title":"Adenosine A2A receptor agonists and PDE inhibitors: A synergistic multitarget mechanism discovered through systematic combination screening in B-cell malignancies","volume":"116","author":"Rickles","year":"2010","journal-title":"Blood"},{"key":"B73","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nrm2455","article-title":"Cancer as an overhealing wound: An old hypothesis revisited","volume":"9","author":"Sch\u00e4fer","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.3390\/ijms23031209","article-title":"Clinical implication of phosphodiesterase-4-inhibition","volume":"23","author":"Schick","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"5431","DOI":"10.1158\/1078-0432.CCR-19-2655","article-title":"AACR cancer progress report 2019: Transforming lives through innovative cancer science","volume":"25","author":"Sengupta","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"B77","doi-asserted-by":"publisher","first-page":"5757","DOI":"10.1158\/1078-0432.CCR-21-3367","article-title":"AACR cancer progress report 2021: Discovery science driving clinical breakthroughs","volume":"27","author":"Sengupta","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1365-2559.2011.04033.x","article-title":"Prostate cancer and inflammation: The evidence","volume":"60","author":"Sfanos","year":"2012","journal-title":"Histopathology"},{"key":"B79","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrurol.2017.167","article-title":"The inflammatory microenvironment and microbiome in prostate cancer development","volume":"15","author":"Sfanos","year":"2018","journal-title":"Nat. Rev. Urol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1016\/j.cellsig.2012.08.007","article-title":"cAMP-dependent protein kinase is essential for hypoxia-mediated epithelial-mesenchymal transition, migration, and invasion in lung cancer cells","volume":"24","author":"Shaikh","year":"2012","journal-title":"Cell. Signal."},{"key":"B81","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"Ca. Cancer J. Clin."},{"key":"B82","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"Ca. Cancer J. Clin."},{"key":"B83","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4103\/aam.aam_56_18","article-title":"Inflammation and cancer","volume":"18","author":"Singh","year":"2019","journal-title":"Ann. Afr. Med."},{"key":"B84","doi-asserted-by":"publisher","first-page":"8","DOI":"10.17305\/bjbms.2018.2756","article-title":"The role of the hedgehog signaling pathway in cancer: A comprehensive review","volume":"18","author":"Skoda","year":"2018","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"B85","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1182\/blood-2004-01-0240","article-title":"The phosphodiesterase PDE4B limits cAMP-associated PI3K\/AKT-dependent apoptosis in diffuse large B-cell lymphoma","volume":"105","author":"Smith","year":"2005","journal-title":"Blood"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1200\/JCO.20.03420","article-title":"Clinical cancer advances 2021: ASCO's report on progress against cancer","volume":"39","author":"Smith","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/1878-0261.12095","article-title":"EMT and inflammation: Inseparable actors of cancer progression","volume":"11","author":"Suarez-Carmona","year":"2017","journal-title":"Mol. Oncol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/leu.2015.302","article-title":"A phosphodiesterase 4B-dependent interplay between tumor cells and the microenvironment regulates angiogenesis in B-cell lymphoma","volume":"30","author":"Suhasini","year":"2016","journal-title":"Leukemia"},{"key":"B89","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ng.2295","article-title":"Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma","volume":"44","author":"Sung","year":"2012","journal-title":"Nat. Genet."},{"key":"B90","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/1759-7714.13328","article-title":"Targeting the PI3K\/Akt\/mTOR pathway in non-small cell lung cancer (NSCLC)","volume":"11","author":"Tan","year":"2020","journal-title":"Thorac. Cancer"},{"key":"B91","doi-asserted-by":"publisher","first-page":"105030","DOI":"10.1016\/j.phrs.2020.105030","article-title":"Blame the signaling: Role of cAMP for the resolution of inflammation","volume":"159","author":"Tavares","year":"2020","journal-title":"Pharmacol. Res."},{"key":"B92","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet"},{"key":"B93","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1124\/jpet.110.173690","article-title":"GSK256066, an exceptionally high-affinity and selective inhibitor of phosphodiesterase 4 suitable for administration by inhalation: In vitro, kinetic, and in vivo characterization","volume":"337","author":"Tralau-Stewart","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B94","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0140-6736(13)62224-2","article-title":"Global cancer patterns: Causes and prevention","volume":"383","author":"Vineis","year":"2014","journal-title":"Lancet"},{"key":"B95","doi-asserted-by":"publisher","first-page":"036501","DOI":"10.1117\/1.JMI.5.3.036501","article-title":"DeepLesion: Automated mining of large-scale lesion annotations and universal lesion detection with deep learning","volume":"5","author":"Yan","year":"2018","journal-title":"J. Med. Imaging"},{"key":"B96","doi-asserted-by":"publisher","first-page":"16389","DOI":"10.3748\/wjg.v20.i44.16389","article-title":"Ulcerative colitis-associated colorectal cancer","volume":"20","author":"Yashiro","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40164-020-00191-1","article-title":"Complex roles of cAMP-PKA-CREB signaling in cancer","volume":"9","author":"Zhang","year":"2020","journal-title":"Exp. Hematol. Oncol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: Signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"B99","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/cam4.650","article-title":"Machine learning-based classification of diffuse large B-cell lymphoma patients by eight gene expression profiles","volume":"5","author":"Zhao","year":"2016","journal-title":"Cancer Med."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.3892\/mmr.2019.9802","article-title":"Anti-inflammatory effect of ciclamilast in an allergic model involving the expression of PDE4B","volume":"19","author":"Zheng","year":"2019","journal-title":"Mol. Med. Rep."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.982130\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T04:55:37Z","timestamp":1665032137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.982130\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,6]]},"references-count":100,"alternative-id":["10.3389\/fphar.2022.982130"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.982130","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,6]]},"article-number":"982130"}}